EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Efficacy and Acceptability of a Mobile App for Monitoring the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease Receiving Home Oxygen Therapy: Randomized Controlled Trial

Anisbed Naranjo-Rojas iD, Luis Ángel Perula-de Torres iD, Freiser Eccehomo Cruz-Mosquera iD, Guillermo Molina-Recio iD

Journal of Medical Internet Research · 2025

DOI: 10.2196/65888 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Medical Internet Research, 2025. Verfasst von Anisbed Naranjo-Rojas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health and Education Research Group (GINEYSA), Faculty of Health, Universidad Santiago de Cali, Santiago de Cali, Colombia. Hauptthemen laut MEDLINE: Mobile Applications, Oxygen Inhalation Therapy, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic obstructive pulmonary disease (COPD) primarily originates from exposure to tobacco smoke, although factors, such as air pollution and exposure to chemicals, also play a role. One of the primary treatments for COPD is oxygen therapy, which helps manage dyspnea and improve survival rates. Mobile health (mHealth) technologies have demonstrated significant potential in monitoring patients with chronic diseases, offering new avenues for enhancing patient care and disease management.

Objective

The purpose of this study was to evaluate the efficacy and acceptability of a mobile app designed for the clinical monitoring of patients with COPD and home oxygen (HO) therapy, compared with conventional monitoring in real-world community settings.

Methods

A parallel-group, nonblinded, multicenter randomized controlled trial was conducted with 45 participants; the intervention group (IG), which used the mobile app in addition to conventional monitoring (n=23) and the control group, which received only conventional monitoring (n=22), administered by therapists over a duration of 3 months. The primary outcomes included the chronic obstructive pulmonary disease assessment test (CAT) score, the level of dyspnea measured by the Borg scale, and oxygen saturation percentage, assessed at both the beginning and end of the trial. Secondary outcomes included the frequency of app use, the number of hospitalizations, and survival rates. In addition, a satisfaction survey and an interview were conducted with the IG.

Results

The median use of the mobile app was 21 (IQR 16-28) days. At the end of the follow-up, the Borg dyspnea scale was significantly lower in patients who used the mobile app for HO therapy monitoring (mean 0.6, SD 0.8 vs mean 4.1, SD 1.4; P=.001). Regarding the impact of COPD on quality of life, as measured by the CAT, no differences were found in the scores between baseline and end-of-follow-up within the control group. However, a significant decrease was observed in the IG (baseline median CAT 27, IQR 23-31 vs final median CAT 22, IQR 14-28; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mobile ApplicationsOxygen Inhalation TherapyPulmonary Disease, Chronic ObstructiveAgedFemaleHumansMaleMiddle AgedHome Care Services

Stichwörter der Autor:innen

chronic obstructive pulmonary diseasehome oxygen therapym-Healthmobile health applicationsmobile phonequality of life

Autor:innen und Institutionen

  • Health and Education Research Group (GINEYSA), Faculty of Health, Universidad Santiago de Cali, Santiago de Cali, Colombia.
  • Biomedicine Doctoral Program, University of Córdoba, Córdoba, Spain.
  • Research Network on Chronicity Primary Care and Health Promotion (RICAPPS), Cooperative Research Networks Oriented to Health Results (RICORS) Carlos III Health Institute, Madrid, Spain.
  • Integral Health Research Group (GISI), Faculty of Health, Universidad Santiago de Cali, Santiago de Cali, Colombia.
  • Nursing Pharmacology and Physiotherapy Department University of Córdoba, Lifestyles Innovation and Health (GA-16) Maimonides Biomedical Research Institute of Córdoba (IMIBIC) Spain, University of Córdoba, Córdoba, Spain.

ORCID-Profile: Anisbed Naranjo-Rojas, Luis Ángel Perula-de Torres, Freiser Eccehomo Cruz-Mosquera, Guillermo Molina-Recio

Zitieren

APA

Naranjo-Rojas, A., Perula-de Torres, L. Á., Cruz-Mosquera, F. E., & Molina-Recio, G. (2025). Efficacy and Acceptability of a Mobile App for Monitoring the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease Receiving Home Oxygen Therapy: Randomized Controlled Trial. Journal of Medical Internet Research. https://doi.org/10.2196/65888

Vancouver

Naranjo-Rojas A, Perula-de Torres LÁ, Cruz-Mosquera FE, Molina-Recio G. Efficacy and Acceptability of a Mobile App for Monitoring the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease Receiving Home Oxygen Therapy: Randomized Controlled Trial. Journal of Medical Internet Research. 2025. doi:10.2196/65888

BibTeX
@article{NaranjoRojas2025,
  author = {Naranjo-Rojas, Anisbed and Perula-de Torres, Luis Ángel and Cruz-Mosquera, Freiser Eccehomo and Molina-Recio, Guillermo},
  title = {Efficacy and Acceptability of a Mobile App for Monitoring the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease Receiving Home Oxygen Therapy: Randomized Controlled Trial},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  doi = {10.2196/65888}
}
Kostenlos starten →